Format

Send to

Choose Destination
Curr Psychiatry Rep. 2013 Jun;15(6):360. doi: 10.1007/s11920-013-0360-9.

Recent advances in neuroimaging biomarkers in geriatric psychiatry.

Author information

1
University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.

Abstract

Neuroimaging, both structural and functional, serve as useful adjuncts to clinical assessment, and can provide objective, reliable means of assessing disease presence and process in the aging population. In the following review we briefly explain current imaging methodologies. Then, we analyze recent developments in developing neuroimaging biomarkers for two highly prevalent disorders in the elderly population- Alzheimer's disease (AD) and late-life depression (LLD). In AD, efforts are focused on early diagnosis through in vivo visualization of disease pathophysiology. In LLD, recent imaging evidence supports the role of white matter ischemic changes in the pathogenesis of depression in the elderly, the "vascular hypothesis." Finally, we discuss potential roles for neuroimaging biomarkers in geriatric psychiatry in the future.

PMID:
23636984
PMCID:
PMC3667151
DOI:
10.1007/s11920-013-0360-9
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center